U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
155611155611BG9924 in Combination With Methotrexate Extension of Study 104RA203TerminatedNo Results AvailableRheumatoid ArthritisDrug: BG9924https://ClinicalTrials.gov/show/NCT00523328
155612155612APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)CompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00523315
155613155613A Pilot Study of TMS Effects on Pain and Depression in Patients With FibromyalgiaCompletedNo Results AvailableMajor Depression|FibromyalgiaDevice: Neotonus model 2100 xxx|Device: Neotonus model 2100 xxxhttps://ClinicalTrials.gov/show/NCT00523302
155614155614Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus BlockActive, not recruitingNo Results AvailableInjuries, Hand|Anesthesia Conduction|Anesthetics, LocalDrug: Bupivacaine|Drug: Ropivacainehttps://ClinicalTrials.gov/show/NCT00523289
155615155615SARS Survivor EvaluationsWithdrawnNo Results AvailableCoronavirus (SARS-CoV)https://ClinicalTrials.gov/show/NCT00523276
155616155616Dacron vs Dardik for Fem-Pop BypassCompletedNo Results AvailableIntermittent Claudication|Arterial Occlusive Diseases|AtheroslerosisDevice: heparin-bonded and collagen coated polyster|Device: Human umbilical vein femoro-popliteal bypasshttps://ClinicalTrials.gov/show/NCT00523263
155617155617Ocular Hypotensive Efficacy of AR-102CompletedNo Results AvailableGlaucomaDrug: AR-102 0.003% Ophthalmic Solution|Drug: AR-102 0.005% Ophthalmic Solution|Drug: AR-102 0.01% Ophthalmic Solution|Drug: AR-102 0.03% Ophthalmic Solution|Drug: AR-102 Vehicle Ophthalmic Solutionhttps://ClinicalTrials.gov/show/NCT00523250
155618155618RAL-eve Study: Raltegravir Substitution StudyCompletedHas ResultsHIV InfectionsDrug: Raltegravirhttps://ClinicalTrials.gov/show/NCT00523237
155619155619ACPs Combined With CABG in Patients With CHFRecruitingNo Results AvailableCongestive Heart FailureProcedure: Angiogenic Cell Precursors(ACPs) or Vescell TM|Biological: Angiogenic Cell Precusorshttps://ClinicalTrials.gov/show/NCT00523224
155620155620Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)CompletedNo Results AvailableHIV Infections|Acquired Immunodeficiency SyndromeDrug: Vicriviroc|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00523211
155621155621Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic ShockCompletedNo Results AvailableSeptic Shockhttps://ClinicalTrials.gov/show/NCT00523198
155622155622A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol WithdrawalCompletedNo Results AvailableAlcohol WithdrawalDrug: Lorazepam|Drug: Diazepamhttps://ClinicalTrials.gov/show/NCT00523185
155623155623Clinical Assessment of Two Manipulative Protocols in Treatment of Hip OsteoarthritisActive, not recruitingNo Results AvailableOsteoarthritis, HipProcedure: manual or manipulative therapy|Procedure: Manual / Manipulative Therapy|Procedure: Supportive Carehttps://ClinicalTrials.gov/show/NCT00523172
155624155624IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable DiseaseCompletedNo Results AvailableRenal Cell CarcinomaDrug: Endoxana, IMA901, Leukine|Drug: IMA901 and Leukinehttps://ClinicalTrials.gov/show/NCT00523159
155625155625Treatment of Primary Menstrual Pain With Kanion CapsuleCompletedNo Results AvailablePrimary DysmenorrheaDrug: Kanion Capsulehttps://ClinicalTrials.gov/show/NCT00523146
155626155626Research on Individualized Treatment for AlcoholismCompletedNo Results AvailableAlcohol DependenceDrug: naltrexone|Drug: naltrexone|Behavioral: Broad Spectrum Treatment|Behavioral: Motivational Enhancement Treatmenthttps://ClinicalTrials.gov/show/NCT00523133
155627155627Topical Voltaren in Otitis ExternaSuspendedNo Results AvailableOtitis ExternaDrug: diclofenac sodium|Drug: dexotchttps://ClinicalTrials.gov/show/NCT00523120
155628155628PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative CareCompletedNo Results AvailableFatigueDrug: PG2https://ClinicalTrials.gov/show/NCT00523107
155629155629Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation ProcedureSuspendedNo Results AvailableEmphysema|Cancerhttps://ClinicalTrials.gov/show/NCT00523094
155630155630Study of Adolescence and DepressionCompletedNo Results AvailableMajor Depressive DisorderBehavioral: Cognitive Behavioral Therapy (CBT)|Behavioral: Active controlhttps://ClinicalTrials.gov/show/NCT00523081
155631155631Pharmacological vs Surgical Treatment for Mixed IncontinenceNot yet recruitingNo Results AvailableMixed Urinary Incontinence|Urinary Incontinence, Stress|Urinary Incontinence, UrgeDrug: Tolterodine|Procedure: tension free vaginal tapehttps://ClinicalTrials.gov/show/NCT00523068
155632155632Ultrasound-guided Supraclavicular Brachial Plexus BlockadeRecruitingNo Results AvailablePainDrug: Lidocainehttps://ClinicalTrials.gov/show/NCT00523055
155633155633Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|AsthmaDrug: insulin aspart|Drug: inhaled human insulinhttps://ClinicalTrials.gov/show/NCT00523042
155634155634Developing a Self-Management Program for People With Depression and Chronic Medical IllnessCompletedNo Results AvailableDepressionBehavioral: Chronic Disease Self-Management Programhttps://ClinicalTrials.gov/show/NCT00523029
155635155635Acupuncture Treatment to Reduce Burning Pain in Spinal Cord InjuryCompletedNo Results AvailableNeuropathic PainProcedure: Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP)|Procedure: Sham acupuncturehttps://ClinicalTrials.gov/show/NCT00523016
155636155636A Controlled Trial of Protein Enrichment of Meal Replacements for Weight Reduction With Retention of Lean Body MassCompletedNo Results AvailableWeight Loss|ObesityDietary Supplement: high protein|Dietary Supplement: standard proteinhttps://ClinicalTrials.gov/show/NCT00523003
155637155637Study to Assess the Safety of Escalating Doses of AT9283, in Patients With LeukemiasTerminatedNo Results AvailableAcute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Chronic Myeloid Leukemia|Myelodysplastic Syndromes|MyelofibrosisDrug: AT9283https://ClinicalTrials.gov/show/NCT00522990
155638155638Echo-Cardiographic Assessment of Cardiovascular Characteristics During Pregnancy and Postpartum PeriodsRecruitingNo Results AvailablePregnancyhttps://ClinicalTrials.gov/show/NCT00522977
155639155639Educational Intervention on Weight Management in Chinese-American ChildrenCompletedNo Results AvailableOverweightBehavioral: behavioral interventionhttps://ClinicalTrials.gov/show/NCT00522964
155640155640SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative StudyCompletedHas ResultsBrain MetastasesDrug: Gadobutrol (Gadavist, Gadovist, BAY86-4875)|Drug: Gadobutrol (Gadavist, Gadovist, BAY86-4875)|Drug: ProHancehttps://ClinicalTrials.gov/show/NCT00522951

* Görseller ve İçerik tekif hakkına sahip olabilir